The Scientist

» malaria and disease/medicine

Most Recent

image: Exploring the Epigenetics of Ethnicity

Exploring the Epigenetics of Ethnicity

By | January 11, 2017

Researchers attempt to estimate how much of the human genome’s methylation patterns can be attributed to genetic ancestry.

0 Comments

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

image: Gene Drives and Other Controversies

Gene Drives and Other Controversies

By | January 1, 2017

Aedes and Anopheles control; three-parent babies; the PhD glut

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

image: Using Gene Drives to Limit the Spread of Malaria

Using Gene Drives to Limit the Spread of Malaria

By | January 1, 2017

Introducing genetic changes into mosquito populations could be key to effective malaria control.

2 Comments

image: Infographic: Using Gene Drive to Control Malaria

Infographic: Using Gene Drive to Control Malaria

By | January 1, 2017

For years, researchers have looked to genetically modify mosquitoes to prevent the spread of malaria. Now they have a promising strategy.

0 Comments

image: UN Rejects Calls for Moratorium on Gene Drive Research

UN Rejects Calls for Moratorium on Gene Drive Research

By | December 23, 2016

Activists claim the technology is too risky, but scientists advise the United Nations to continue to support gene drive research.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

A family’s collection of antique microscope slides became a trove of genetic information about the eradicated European malaria pathogen.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS